{{Template:PBB/7172}}

'''硫嘌呤甲基转移酶'''（{{lang-en|'''Thiopurine methyltransferase'''或'''Thiopurine S-methyltransferase'''}}，{{EC number|2.1.1.67}}），又称'''巯基嘌呤甲基转移酶'''或'''巯嘌呤甲基转移酶'''，简称'''TPMT'''，是一种催化[[硫嘌呤类|硫嘌呤类]]化合物[[甲基化|甲基化]]的[[酶|酶]]。硫嘌呤类药物常用于癌症[[化学疗法|化学疗法]]及[[免疫抑制|免疫抑制]]疗法，因而TPMT的活性会影响使用这类药物时不同患者对药物的敏感性和[[毒性|毒性]]反应。<ref name="entrez" /><ref name="duo" />

TPMT在18q[[染色体|染色体]]上有一个伪基因。<ref name="entrez">{{cite web | title = Entrez Gene: TPMT thiopurine S-methyltransferase| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7172| accessdate =2012-07-02 |publisher=[[美国国家生物技术信息中心|美国国家生物技术信息中心]] }}</ref><ref>{{Cite journal | last1 = Lee | first1 = D. | last2 = Szumlanski | first2 = C. | last3 = Houtman | first3 = J. | last4 = Honchel | first4 = R. | last5 = Rojas | first5 = K. | last6 = Overhauser | first6 = J. | last7 = Wieben | first7 = E. D. 
| last8 = Weinshilboum | first8 = R. M. | title = Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1 | journal = Drug metabolism and disposition: the biological fate of chemicals | volume = 23 | issue = 3 | pages = 398–405 | year = 1995 | pmid = 7628307 }}</ref>

==药理学==
TPMT是硫嘌呤类药物（如[[硫唑嘌呤|硫唑嘌呤]]、[[巯嘌呤|巯嘌呤]]和[[硫鸟嘌呤|硫鸟嘌呤]]）的代谢中最主要的酶之一，起到的作用是在这类化合物的[[硫|硫]]原子上增加一个甲基；这个过程中提供甲基的是[[S-腺苷甲硫氨酸|S-腺苷甲硫氨酸]]，后者同时被转化成[[S-腺苷-L-高半胱氨酸|S-腺苷-L-高半胱氨酸]]。<ref name="xl">{{Cite journal | last1 = Weinshilboum | first1 = R. M. | last2 = Sladek | first2 = S. L. | title = Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity | journal = American journal of human genetics | volume = 32 | issue = 5 | pages = 651–662 | year = 1980 | pmid = 7191632 | pmc = 1686086 }}</ref> TPMT基因的缺陷会让人体无法将这类药物灭活，未代谢的药物因此在体内大量累积，从而引起严重甚至致命的[[骨髓抑制|骨髓抑制]]，表现为[[贫血|贫血]]、[[血小板减少症|血小板减少症]]（导致[[出血|出血]]）和[[白细胞减少症|白细胞减少症]]（导致[[感染|感染]]）等。<ref name="duo">{{Cite journal | last1 = Yates | first1 = C. R. | last2 = Krynetski | first2 = E. Y. | last3 = Loennechen | first3 = T. | last4 = Fessing | first4 = M. Y. | last5 = Tai | first5 = H. L. | last6 = Pui | first6 = C. H. | last7 = Relling | first7 = M. V. | last8 = Evans | first8 = W. E. | title = Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance | journal = Annals of internal medicine | volume = 126 | issue = 8 | pages = 608–614 | year = 1997 | pmid = 9103127}}</ref><ref name="pmid17691917">{{cite journal|author=Fujita K, Sasaki Y |title=Pharmacogenomics in drug-metabolizing enzymes catalyzing anticancer drugs for personalized cancer chemotherapy |journal=Curr. Drug Metab. |volume=8 |issue=6 |pages=554–62 |pmid=17691917 |url=http://www.bentham-direct.org/pages/content.php?CDM/2007/00000008/00000006/0002F.SGM |doi=10.2174/138920007781368890 |date=August 2007 |deadurl=yes |archiveurl=https://archive.is/20130112103320/http://www.bentham-direct.org/pages/content.php?CDM/2007/00000008/00000006/0002F.SGM |archivedate=2013-01-12 }}</ref>

==临床意义==
研究显示，临床上大约5%的硫嘌呤类药物疗法由于毒性原因而终止。<ref>{{cite journal | pmid = 14634700 | doi=10.1007/s00228-003-0698-8 | volume=59 | issue=11 | title=Thiopurine methyltransferase (TPMT) genotype distribution in azathioprine-tolerant and -intolerant patients with various disorders. The impact of TPMT genotyping in predicting toxicity | journal=Eur. J. Clin. Pharmacol. | pages=797–801 | author=Reuther LO, Vainer B, Sonne J, Larsen NE|date=January 2004}}</ref> 一般来说，在使用硫嘌呤类药物前及治疗过程中会多次测量病人的TPMT酶活性，以防止TPMT不活跃者（占总人口约10%）及TPMT无活性者（占总人口约0.3%）在使用这类药物后产生的严重[[骨髓|骨髓]]毒性。<ref name="xl" /> 近年来也开始采用[[基因测试|基因测试]]，相对于前者优点在于测试不需要反复进行。<ref>{{Cite journal | last1 = Payne | first1 = K. | last2 = Newman | first2 = W. | last3 = Fargher | first3 = E. | last4 = Tricker | first4 = K. | last5 = Bruce | first5 = I. N. | last6 = Ollier | first6 = W. E. R. | doi = 10.1093/rheumatology/kel427 | title = TPMT testing in rheumatology: Any better than routine monitoring? | journal = Rheumatology | volume = 46 | issue = 5 | pages = 727–729 | year = 2007 | pmid = 17255139 | pmc = }}</ref>

不同[[人种|人种]]的TPMT[[基因突变|基因突变]]分布情况有着极大的不同。<ref name="urlHuman Gene TPMT (uc003ncm.1) Description and Page Index">{{cite web | url = http://genome.ucsc.edu/cgi-bin/hgGene?hgg_gene=uc003ncm.1&hgg_prot=P51580&hgg_chrom=chr6&hgg_start=18236523&hgg_end=18263353&hgg_type=knownGene&db=hg18&hgsid=97455887 | title = Human Gene TPMT (uc003ncm.1) | author = Genome Bioinformatics Group, Center for Biomolecular Science and Engineering | authorlink = | coauthors = | date = | format = | work = UCSC Genome Browser | publisher = University of California Santa Cruz | pages = | language = | archiveurl = | archivedate = | quote = | accessdate = 2008-07-25}}</ref>

==参考资料==
{{reflist}}

{{PDB Gallery|geneid=7172}}
{{EC 2.1}}

[[Category:EC_2.1.1|Category:EC 2.1.1]]